Victory Capital Management Inc. Purchases New Stake in Enfusion, Inc. (NYSE:ENFN)

Victory Capital Management Inc. acquired a new stake in Enfusion, Inc. (NYSE:ENFN) during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 21,474 shares of the company’s stock, valued at approximately $183,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Brown Capital Management LLC lifted its stake in shares of Enfusion by 6.5% in the fourth quarter. Brown Capital Management LLC now owns 11,817,661 shares of the company’s stock worth $114,631,000 after acquiring an additional 724,502 shares during the period. Scalar Gauge Management LLC purchased a new position in shares of Enfusion in the fourth quarter worth about $1,993,000. Wasatch Advisors LP boosted its holdings in shares of Enfusion by 34.2% in the first quarter. Wasatch Advisors LP now owns 792,083 shares of the company’s stock worth $7,327,000 after acquiring an additional 201,771 shares during the period. Vanguard Group Inc. lifted its holdings in shares of Enfusion by 1.4% in the first quarter. Vanguard Group Inc. now owns 3,653,189 shares of the company’s stock worth $33,792,000 after buying an additional 51,670 shares in the last quarter. Finally, Principal Financial Group Inc. bought a new position in shares of Enfusion in the first quarter worth $452,000. Institutional investors own 81.05% of the company’s stock.

Enfusion Price Performance

Shares of Enfusion stock opened at $9.58 on Wednesday. The company has a 50 day simple moving average of $8.55 and a two-hundred day simple moving average of $8.89. Enfusion, Inc. has a 1 year low of $7.52 and a 1 year high of $10.45. The firm has a market cap of $1.23 billion, a PE ratio of 319.33, a PEG ratio of 2.23 and a beta of 0.90.

Enfusion (NYSE:ENFN) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $0.02 EPS for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.01). The firm had revenue of $49.46 million for the quarter, compared to the consensus estimate of $50.27 million. Enfusion had a net margin of 1.98% and a return on equity of 6.17%. As a group, research analysts anticipate that Enfusion, Inc. will post 0.07 earnings per share for the current year.

About Enfusion

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.